Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC)

By Nagalakshmi K.   Jamil Kaiser   Pingali Usharani   Reddy M. Vishnuvardhan   Attili Suresh S. V.  

Biomarkers, Vol. 19, Iss. 3, 2014-05 ,pp. : 198-206

Informa Healthcare

Access to resources Recommend Favorite

Role of Ca²⁺-Independent Phospholipase A₂ and Cyclooxygenase/Lipoxygenase Pathways in the Nitric Oxide Production by Murine Macrophages Stimulated by Lipopolysaccharides

By Vivancos M.   Moreno J.J.  

Nitric Oxide, Vol. 6, Iss. 3, 2002-05 ,pp. : 255-262

Academic Press

Access to resources Recommend Favorite

Novel Agents Targeting Crucial Signalling Pathways in Head and Neck Squamous Cell Carcinoma, HNSCC - Preclinical Development and Data from Clinical Trials

By  

Current Proteomics, Vol. 10, Iss. 2, 2013-07 ,pp. : 150-164

Bentham Science Publishers

Access to resources Recommend Favorite

The role of cetuximab in the treatment of squamous cell cancer of the head and neck

By Burtness Barbara  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 8, 2005-08 ,pp. : 1085-1093

Informa Healthcare

Access to resources Recommend Favorite

Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma

By Chiu Tai-Jan   Chen Yi-Ju   Rau Kun-Ming   Chen Chang-Han   Chien Chih-Yen   Li Shau-Hsuan   Tsai Hsin-Ting   Eng Hock-Liew  

Biomarkers, Vol. 18, Iss. 8, 2013-12 ,pp. : 687-698

Informa Healthcare

Access to resources Recommend Favorite